Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD. Zephir H, Poupart J, Deschamps R, Audoin B, et al. Neurology 2021;96:295-296.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zephir H, Poupart J, Deschamps R, Audoin B, et al. Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD. Neurology 2021;96:295-296.
PMID: 33558403